Mary Ann E. Moore - Mar 1, 2023 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Role
EVP, General Counsel & Sec
Signature
/s/ Mary Ann E. Moore
Stock symbol
MD
Transactions as of
Mar 1, 2023
Transactions value $
-$36,910
Form type
4
Date filed
3/3/2023, 04:00 PM
Previous filing
Mar 3, 2022
Next filing
Dec 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MD Common Stock Award $0 +55.7K +191.71% $0.00 84.7K Mar 1, 2023 Direct F2, F3
transaction MD Common Stock Tax liability -$36.9K -2.35K -2.77% $15.74 82.4K Mar 1, 2023 Direct F4
holding MD Common Stock 16.9K Mar 1, 2023 By Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person and her spouse are trustees of the trust that holds the reported securities. The reporting person disclaims beneficial interest of the reported securities except to the extent of her pecuniary interest therein.
F2 Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2024, twenty-five percent (25%) of the restricted shares will vest on March 1, 2025 and fifty percent (50%) of the restricted shares will vest on March 1, 2026, subject to the terms of the Plan.
F3 Excludes 16,340 previously reported shares of restricted common stock granted to the reporting person pursuant to the Plan in connection with an annual equity award that were forfeited because the performance-based criteria were not achieved.
F4 Represents 2,345 restricted shares withheld for payment of taxes upon vesting of shares.